304 related articles for article (PubMed ID: 27634883)
1. RNPC1 enhances progesterone receptor functions by regulating its mRNA stability in breast cancer.
Lou P; Li C; Shi L; Xia TS; Zhou W; Wu J; Zhou X; Li X; Wang Y; Wei JF; Ding Q
Oncotarget; 2017 Mar; 8(10):16387-16400. PubMed ID: 27634883
[TBL] [Abstract][Full Text] [Related]
2. [Regulatory effect and mechanism of RNA binding motif protein 38 on the expression of progesterone receptor in human breast cancer ZR-75-1 cells].
Lou PP; Li CL; Xia TS; Shi L; Wu J; Zhou XJ; Wang Y; Ding Q
Zhonghua Zhong Liu Za Zhi; 2016 Jun; 38(6):425-9. PubMed ID: 27346399
[TBL] [Abstract][Full Text] [Related]
3. RNA-binding protein RNPC1: acting as a tumor suppressor in breast cancer.
Xue JQ; Xia TS; Liang XQ; Zhou W; Cheng L; Shi L; Wang Y; Ding Q
BMC Cancer; 2014 May; 14():322. PubMed ID: 24884756
[TBL] [Abstract][Full Text] [Related]
4. RNPC1, an RNA-binding protein and a p53 target, regulates macrophage inhibitory cytokine-1 (MIC-1) expression through mRNA stability.
Yin T; Cho SJ; Chen X
J Biol Chem; 2013 Aug; 288(33):23680-6. PubMed ID: 23836903
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor (ER) was regulated by RNPC1 stabilizing mRNA in ER positive breast cancer.
Shi L; Xia TS; Wei XL; Zhou W; Xue J; Cheng L; Lou P; Li C; Wang Y; Wei JF; Ding Q
Oncotarget; 2015 May; 6(14):12264-78. PubMed ID: 25881544
[TBL] [Abstract][Full Text] [Related]
6. RNA-binding protein RNPC1 acts as an oncogene in gastric cancer by stabilizing aurora kinase B mRNA.
Ji CM; Zhang X; Fang W; Meng L; Wei X; Lu C
Exp Cell Res; 2021 Sep; 406(1):112741. PubMed ID: 34302858
[TBL] [Abstract][Full Text] [Related]
7. RNA Binding Protein RNPC1 Inhibits Breast Cancer Cell Metastasis via Activating STARD13-Correlated ceRNA Network.
Zheng L; Zhang Z; Zhang S; Guo Q; Zhang F; Gao L; Ni H; Guo X; Xiang C; Xi T
Mol Pharm; 2018 Jun; 15(6):2123-2132. PubMed ID: 29733656
[TBL] [Abstract][Full Text] [Related]
8. RNPC1, an RNA-binding protein and a target of the p53 family, regulates p63 expression through mRNA stability.
Zhang J; Jun Cho S; Chen X
Proc Natl Acad Sci U S A; 2010 May; 107(21):9614-9. PubMed ID: 20457941
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.
Rivas MA; Venturutti L; Huang YW; Schillaci R; Huang TH; Elizalde PV
Breast Cancer Res; 2012 May; 14(3):R77. PubMed ID: 22583478
[TBL] [Abstract][Full Text] [Related]
10. PTEN expression is upregulated by a RNA-binding protein RBM38 via enhancing its mRNA stability in breast cancer.
Zhou XJ; Wu J; Shi L; Li XX; Zhu L; Sun X; Qian JY; Wang Y; Wei JF; Ding Q
J Exp Clin Cancer Res; 2017 Oct; 36(1):149. PubMed ID: 29052531
[TBL] [Abstract][Full Text] [Related]
11. RNPC1 modulates the RNA-binding activity of, and cooperates with, HuR to regulate p21 mRNA stability.
Cho SJ; Zhang J; Chen X
Nucleic Acids Res; 2010 Apr; 38(7):2256-67. PubMed ID: 20064878
[TBL] [Abstract][Full Text] [Related]
12. Breast Cancer Suppression by Progesterone Receptors Is Mediated by Their Modulation of Estrogen Receptors and RNA Polymerase III.
Finlay-Schultz J; Gillen AE; Brechbuhl HM; Ivie JJ; Matthews SB; Jacobsen BM; Bentley DL; Kabos P; Sartorius CA
Cancer Res; 2017 Sep; 77(18):4934-4946. PubMed ID: 28729413
[TBL] [Abstract][Full Text] [Related]
13. Progestin effects on breast cancer cell proliferation, proteases activation, and in vivo development of metastatic phenotype all depend on progesterone receptor capacity to activate cytoplasmic signaling pathways.
Carnevale RP; Proietti CJ; Salatino M; Urtreger A; Peluffo G; Edwards DP; Boonyaratanakornkit V; Charreau EH; Bal de Kier Joffé E; Schillaci R; Elizalde PV
Mol Endocrinol; 2007 Jun; 21(6):1335-58. PubMed ID: 17440047
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel AU-Rich element in the 3' untranslated region of epidermal growth factor receptor mRNA that is the target for regulated RNA-binding proteins.
Balmer LA; Beveridge DJ; Jazayeri JA; Thomson AM; Walker CE; Leedman PJ
Mol Cell Biol; 2001 Mar; 21(6):2070-84. PubMed ID: 11238942
[TBL] [Abstract][Full Text] [Related]
15. Progesterone receptor activation downregulates GATA3 by transcriptional repression and increased protein turnover promoting breast tumor growth.
Izzo F; Mercogliano F; Venturutti L; Tkach M; Inurrigarro G; Schillaci R; Cerchietti L; Elizalde PV; Proietti CJ
Breast Cancer Res; 2014 Dec; 16(6):491. PubMed ID: 25479686
[TBL] [Abstract][Full Text] [Related]
16. TReP-132 is a novel progesterone receptor coactivator required for the inhibition of breast cancer cell growth and enhancement of differentiation by progesterone.
Gizard F; Robillard R; Gross B; Barbier O; Révillion F; Peyrat JP; Torpier G; Hum DW; Staels B
Mol Cell Biol; 2006 Oct; 26(20):7632-44. PubMed ID: 17015480
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA regulation of progesterone receptor in breast cancer.
Gilam A; Shai A; Ashkenazi I; Sarid LA; Drobot A; Bickel A; Shomron N
Oncotarget; 2017 Apr; 8(16):25963-25976. PubMed ID: 28404930
[TBL] [Abstract][Full Text] [Related]
18. PPM1D phosphatase, a target of p53 and RBM38 RNA-binding protein, inhibits p53 mRNA translation via dephosphorylation of RBM38.
Zhang M; Xu E; Zhang J; Chen X
Oncogene; 2015 Nov; 34(48):5900-11. PubMed ID: 25823026
[TBL] [Abstract][Full Text] [Related]
19. The RNA-binding protein RNPC1 stabilizes the mRNA encoding the RNA-binding protein HuR and cooperates with HuR to suppress cell proliferation.
Cho SJ; Jung YS; Zhang J; Chen X
J Biol Chem; 2012 Apr; 287(18):14535-44. PubMed ID: 22371495
[TBL] [Abstract][Full Text] [Related]
20. Nicotine-induced human breast cancer cell proliferation attenuated by garcinol through down-regulation of the nicotinic receptor and cyclin D3 proteins.
Chen CS; Lee CH; Hsieh CD; Ho CT; Pan MH; Huang CS; Tu SH; Wang YJ; Chen LC; Chang YJ; Wei PL; Yang YY; Wu CH; Ho YS
Breast Cancer Res Treat; 2011 Jan; 125(1):73-87. PubMed ID: 20229177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
